Getinge’s decision to leave the surgical perfusion market will benefit LivaNova, an already dominant player in the sector ...

Innovative approaches to streamlining biologics production with integrated continuous technologies. Continuous manufacturing ...

Getinge plans to phase out its surgical perfusion business in a move expected to benefit major players such as LivaNova, ...

People who can exercise sufficiently on a treadmill during cardiac stress testing have a lower mortality risk regardless of ...

The KidneyVault Portable Renal Perfusion System received FDA clearance in October of 2024. The lightweight device is designed for convenient end-to-end hypothermic perfusion, offering new levels ...

North America remains the largest market for skin perfusion pressure testing devices, driven by rising cardiovascular disease ...

This blended learning programme integrates academic knowledge and understanding of perfusion science with both the needs of the working professional clinical perfusion scientist and the demands of ...

GlobalData’s latest report reveals global CBPE market expected to grow at a CAGR of 1.2 per cent from $508.2 million in 2024 ...

The study suggests that transplant teams and organ procurement organizations should not be discouraged from pursuing DCD heart donations. Strategies to preserve hearts donated after circulatory death ...

RenovoRx (RNXT) highlighted its recent abstract presentation at the 2025 Society of Interventional Oncology Annual Conference in Las Vegas, ...